Correlation Between XOMA Corp and Eliem Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XOMA Corp and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XOMA Corp and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XOMA Corp and Eliem Therapeutics, you can compare the effects of market volatilities on XOMA Corp and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XOMA Corp with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of XOMA Corp and Eliem Therapeutics.

Diversification Opportunities for XOMA Corp and Eliem Therapeutics

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between XOMA and Eliem is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding XOMA Corp and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and XOMA Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XOMA Corp are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of XOMA Corp i.e., XOMA Corp and Eliem Therapeutics go up and down completely randomly.

Pair Corralation between XOMA Corp and Eliem Therapeutics

Given the investment horizon of 90 days XOMA Corp is expected to generate 0.53 times more return on investment than Eliem Therapeutics. However, XOMA Corp is 1.87 times less risky than Eliem Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  1,774  in XOMA Corp on August 31, 2024 and sell it today you would earn a total of  1,571  from holding XOMA Corp or generate 88.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.47%
ValuesDaily Returns

XOMA Corp  vs.  Eliem Therapeutics

 Performance 
       Timeline  
XOMA Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting primary indicators, XOMA Corp sustained solid returns over the last few months and may actually be approaching a breakup point.
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

XOMA Corp and Eliem Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XOMA Corp and Eliem Therapeutics

The main advantage of trading using opposite XOMA Corp and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XOMA Corp position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.
The idea behind XOMA Corp and Eliem Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon